Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment
Strontium89 Now Reimbursed in All Treatment Settings PR Newswire NEW YORK, Jan. 7, 2021 NEW YORK, Jan. 7, 2021 /PRNewswire/ — Q BioMed
Read moreStrontium89 Now Reimbursed in All Treatment Settings PR Newswire NEW YORK, Jan. 7, 2021 NEW YORK, Jan. 7, 2021 /PRNewswire/ — Q BioMed
Read moreNewsfile Corp.Newsfile Corp Phoenix, Arizona–(Newsfile Corp. – October 14, 2020) – The Stock Day Podcast welcomed Q BioMed Inc. (OTCQB:
Read moreAUSTIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q
Read moreSeveral International Market Authorisations Expected in Q4 Expanding Access to South and Central America and Asia PR Newswire NEW YORK,
Read moreCOVID-19 clinical trial planned for Q1 2021 supported by Canadian Government Proof of concept would validate platform for multiple indications
Read morePR Newswire NEW YORK, Aug. 11, 2020 NEW YORK, Aug. 11, 2020 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced
Read moreCaligor Coghlan Pharma Services to Distribute Strontium89 (Strontium Chloride Injection Sr-89 USP) Outside the United States Agreement opens international markets
Read moreNEW YORK, April 30, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and Q BioMed Inc. (OTCQB: QBIO) (the “Company”), a
Read moreNewsfile Corp.Newsfile Corp Phoenix, Arizona–(Newsfile Corp. – April 27, 2020) – The Stock Day Podcast welcomed Q BioMed Inc. (OTCQB:
Read moreInitial focus on global rollout of Strontium89 PR Newswire NEW YORK, March 31, 2020 NEW YORK, March 31, 2020 /PRNewswire/ — Q BioMed
Read more